BHG

SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)

SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

8-K - Bright Health Group Inc. (0001671284) (Filer)

The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement servicesBright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock Exc

The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

Shares of RxSight, Inc. (NASDAQ:RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ:HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ:AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value

8-K - Bright Health Group Inc. (0001671284) (Filer)

Gainers Omega Therapeutics (NASDAQ:OMGA) shares increased by 99.6% to $5.45 during Thursday's regular session. The market value of their outstanding shares is at $300.5 million. Avenue Therapeutics (NASDAQ:ATXI) shares increased by 56.08% to $0.27. The company's market cap stands at $3.6 million. Dyne Therapeutics (NASDAQ:DYN) stock rose 30.28% to $19.24. The market value of their outstanding shares is at $1.1 billion. Adicet Bio (NASDAQ:ACET) shares moved upwards by 25.0% to $2.2. The company's market cap stands at $94.9 million. Bright Health Gr (NYSE:BHG) stock increased by 24.15% to $11.36. The company's market cap stands at $90.6 million. Werewolf Therapeutics (NASDAQ:HOWL) shares

8-K - Bright Health Group Inc. (0001671284) (Filer)

Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

8-K - Bright Health Group Inc. (0001671284) (Filer)

Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

  The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document. Medical Home Network (MHN) provider partners participating in NeueHealth Premier ACO achieved $10.1 million in gross savings and a 100% quality score in the 2022 performance year, according to data recently released from the Centers for Medicare and Medicaid Services (CMS). These results were achieved under the Global and Professional Direct Contracting Model, now known as the ACO Realizing Equity, Access, and Community Health (REACH) Mode

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)

4 - Bright Health Group Inc. (0001671284) (Issuer)